|
Volumn 157, Issue 2, 2012, Pages 252-254
|
Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy
|
Author keywords
Chemotherapy; High dose methotrexate; Intravitreous methotrexate injection; Primary intraocular lymphoma; Reduced whole brain radiotherapy
|
Indexed keywords
IMMUNOGLOBULIN HEAVY CHAIN;
INTERLEUKIN 10;
INTERLEUKIN 6;
METHOTREXATE;
PROCARBAZINE;
RITUXIMAB;
VINCRISTINE;
ADULT;
AGED;
BONE MARROW BIOPSY;
BRAIN LYMPHOMA;
CANCER RELAPSE;
CATARACT;
CLINICAL ARTICLE;
COMPUTER ASSISTED TOMOGRAPHY;
CONJUNCTIVITIS;
CYTOLOGY;
DISEASE FREE SURVIVAL;
DRUG MEGADOSE;
FEBRILE NEUTROPENIA;
FEMALE;
FLOW CYTOMETRY;
FOLLOW UP;
HUMAN;
INTRAOCULAR LYMPHOMA;
KERATITIS;
LETTER;
LUMBAR PUNCTURE;
LYMPHOMA;
MALE;
MUCOSA INFLAMMATION;
MULTIPLE CYCLE TREATMENT;
NAUSEA AND VOMITING;
NEUROLOGIC DISEASE;
NEUTROPENIA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OVERALL SURVIVAL;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
RADIATION DOSE FRACTIONATION;
RADIOTHERAPY;
TREATMENT OUTCOME;
VISUAL SYSTEM EXAMINATION;
VITRECTOMY;
WHOLE BRAIN RADIOTHERAPY;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRAIN;
EYE NEOPLASMS;
FEMALE;
HUMANS;
LYMPHOMA;
MALE;
METHOTREXATE;
MIDDLE AGED;
PROCARBAZINE;
RADIOTHERAPY;
VINCRISTINE;
|
EID: 84859211208
PISSN: 00071048
EISSN: 13652141
Source Type: Journal
DOI: 10.1111/j.1365-2141.2011.08938.x Document Type: Letter |
Times cited : (25)
|
References (9)
|